Compounds > cefazolin
Page last updated: 2024-08-23

cefazolin and Esophageal Varices

cefazolin has been researched along with Esophageal Varices in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuah, SK; Hu, TH; Lee, CH; Lu, SN; Tai, WC; Wang, JH; Wu, CK; Wu, KL1
Changchien, CS; Chiou, SS; Chuah, SK; Hu, TH; Lu, SN; Tsai, MS; Wang, JH; Wu, KL; Xu, HW1
Brown-Castillo, J; Fujii, Y; Mammen, EF; Nakumura, R; Ozawa, T; Sugawa, C1
Bucci, LA; Gutta, K; Lucas, CE; Nakamura, R; Sferra, C; Sugawa, C; Sugimura, Y1
Geller, ER; Lyons, SD; Sugawa, C; Vandenberg, DM1
Groitl, H1

Other Studies

6 other study(ies) available for cefazolin and Esophageal Varices

ArticleYear
The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Acute Disease; Administration, Intravenous; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Gram-Negative Bacterial Infections; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Pneumonia; Retrospective Studies; Sepsis; Treatment Outcome

2013
The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions.
    Surgical endoscopy, 2011, Volume: 25, Issue:9

    Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Cefazolin; Cross Infection; Cross-Sectional Studies; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Length of Stay; Liver Cirrhosis; Male; Peritonitis; Postoperative Complications; Recurrence; Retrospective Studies; Young Adult

2011
Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
    The American surgeon, 1991, Volume: 57, Issue:4

    Topics: Adult; Aged; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Cefazolin; Esophageal and Gastric Varices; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibronectins; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Peptide Hydrolases; Plasminogen Inactivators; Protein C; Sclerotherapy; Sodium Tetradecyl Sulfate; Thrombin; Tissue Plasminogen Activator

1991
Sclerotherapy of bleeding esophageal varices using a thrombogenic cocktail.
    The American surgeon, 1991, Volume: 57, Issue:4

    Topics: Adolescent; Adult; Aged; Cefazolin; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Patient Compliance; Recurrence; Sclerotherapy; Sodium Tetradecyl Sulfate; Thrombin

1991
Comparison of 1% sodium tetradecyl sulfate to a thrombogenic sclerosant cocktail for endoscopic sclerotherapy.
    The American surgeon, 1988, Volume: 54, Issue:2

    Topics: Adult; Aged; Blood Transfusion; Cefazolin; Drug Combinations; Endoscopy; Esophageal and Gastric Varices; Fatty Alcohols; Female; Gastrointestinal Hemorrhage; Humans; Length of Stay; Male; Middle Aged; Recurrence; Retrospective Studies; Sodium Tetradecyl Sulfate; Thrombin

1988
A new sclerosant cocktail.
    Surgical endoscopy, 1987, Volume: 1, Issue:2

    Topics: Cefazolin; Drug Combinations; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Recurrence; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Thrombin

1987